ArticleInternational journal of general medicine2025
Combined Analysis of Protein Induced by Prothrombin Induced by Vitamin K Absence (PIVKA) and Alpha-L-Fucosidase (AFU) with Alpha-Fetoprotein (AFP) May Improve the Diagnostic Efficacy for Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The aim of this study was to explore the value of biomarkers such as prothrombin induced by vitamin K absence (PIVKA), osteopontin (OPN), α-L-fucoidase (AFU), interleukin-6 (IL-6), and Golgi protein 73 (GP73) in the diagnosis of chronic hepatitis B (CHB), hepatitis B liver cirrhosis (HBV-LC), and hepatocellular carcinoma (HCC). Methods: A total of 264 male patients were included in this study, including CHB (n=88), HBV-LC (n=88), and HCC (n=88). The levels of PIVKA, OPN, AFU, alpha-fetoprotein (AFP), IL6, and GP73 of the subjects were detected respectively, and the differences in the levels of serum PIVKA, OPN, AFU, AFP, IL6 and GP73 among the groups were compared. The correlations among various indicators were analyzed, and the diagnostic value of these indicators for HBV-LC and HCC was evaluated through the receiver operating characteristic (ROC) curve analysis. Results: The levels of PIVKA, OPN, AFP, AFU, IL6, and GP73 in patients with HBV-LC, HCC were significantly higher than those in patients with CHB, respectively. In patients with HBV-LC and HCC, no significant correlation was shown between AFP and other markers, suggesting that AFP may have an independent mechanism of action different from other markers in HBV-LC and HCC. OPN had the highest diagnostic efficacy, with an area under the ROC curve (AUC) of 0.855 in diagnosis of HBV-LC, followed by GP73 and IL6. AFU had the highest diagnostic efficacy in diagnosis of HCC, followed by AFP and OPN. In terms of combined detection, the diagnostic efficacy of AFP+AFU (AUC=0.785, 95% CI: 0.714-0.855) and AFP+PIVKA (AUC=0.635, 95% CI: 0.553-0.718) were better than AFP in diagnosing HBV-LC; and the diagnostic efficacy of AFP+AFU (AUC=0.878, 95% CI: 0.822-0.934) was better than AFP in diagnosing HCC. Conclusion: Combined analysis of PIVKA and AFU with AFP may improve the diagnostic efficacy for HBV-LC and HCC in CHB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.